Xiaodong Wang - 24 Jun 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Role
Director, Chair, Scientific Advisory Brd
Signature
/s/ Qing Nian, as Attorney-in-Fact
Issuer symbol
ONC
Transactions as of
24 Jun 2025
Net transactions value
-$532,867
Form type
4
Filing time
25 Jun 2025, 17:08:08 UTC
Previous filing
12 Jun 2025
Next filing
11 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wang Xiaodong Director, Chair, Scientific Advisory Brd C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND /s/ Qing Nian, as Attorney-in-Fact 25 Jun 2025 0001662982

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONC American Depositary Shares Sale $79,050 -300 -15% $263.50 1,707 24 Jun 2025 Direct F4, F5, F6
transaction ONC American Depositary Shares Sale $291,888 -1,100 -64% $265.35 607 24 Jun 2025 Direct F4, F5, F7
transaction ONC American Depositary Shares Sale $135,149 -507 -84% $266.57 100 24 Jun 2025 Direct F4, F5, F8
transaction ONC American Depositary Shares Sale $26,781 -100 -100% $267.81 0 24 Jun 2025 Direct F4, F5
holding ONC Ordinary Shares 5,154,770 24 Jun 2025 Direct
holding ONC Ordinary Shares 1,025,063 24 Jun 2025 See Footnote F1
holding ONC Ordinary Shares 3,953,100 24 Jun 2025 See Footnote F2
holding ONC Ordinary Shares 50 24 Jun 2025 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
F2 These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
F3 These securities are held by the spouse of the Reporting Person.
F4 Each American Depositary Share represents 13 Ordinary Shares.
F5 The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 12, 2024.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.40 to $263.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.02 to $265.86, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.27 to $266.95, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.